Omer Gendelman Selected Research

Omer Gendelman Research Topics

2	Psoriatic Arthritis 01/2022 - 10/2018
2	Fibromyalgia (Fibrositis) 11/2021 - 10/2017
2	COVID-19 01/2021 - 07/2020
2	Infections 01/2021 - 07/2020
1	Osteoporosis 10/2022
1	Breast Neoplasms (Breast Cancer) 10/2022
1	Osteitis Deformans (Paget's Disease of Bone) 10/2022
1	Back Pain (Backache) 08/2022
1	Pneumonia (Pneumonitis) 01/2021
1	Bacterial Infections (Bacterial Infection) 01/2021
1	Cytokine Release Syndrome 01/2021
1	Rheumatic Diseases (Rheumatism) 07/2020
1	Necrosis 10/2018
1	Hypertension (High Blood Pressure) 04/2018
1	Hyperlipidemias (Hyperlipidemia) 04/2018
1	Diabetes Mellitus 04/2018
1	Rheumatoid Arthritis 09/2015
1	Nephrosis 09/2015
1	Nephrotic Syndrome (Syndrome, Nephrotic) 09/2015
1	Amyloidosis 09/2015
1	Lupus Nephritis 05/2015
1	Proteinuria 05/2015
1	Glomerulonephritis 05/2015
1	Tumor Lysis Syndrome 07/2014
1	Melanoma (Melanoma, Malignant) 07/2014

2	Pharmaceutical PreparationsIBA 01/2022 - 11/2021
1	Diphosphonates (Bisphosphonates)IBA 10/2022
1	O,O-diisopropyl-S-benzylthiophosphate (IBP)IBA 08/2022
1	secukinumabIBA 01/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022
1	tocilizumab (atlizumab)FDA Link 01/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021
1	Colchicine FDA LinkGeneric 07/2020
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 07/2020
1	golimumab FDA Link 10/2018
1	Monoclonal AntibodiesIBA 10/2018
1	Methotrexate (Mexate)FDA LinkGeneric 10/2018
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 04/2018
1	Rituximab (Mabthera)FDA Link 09/2015
1	Immunoglobulins (Immunoglobulin)IBA 05/2015
1	CytokinesIBA 05/2015
1	tuftsin-phosphorylcholineIBA 05/2015

3	Therapeutics 01/2021 - 10/2017
2	Drug Therapy (Chemotherapy) 10/2017 - 09/2015
1	Artificial Respiration (Mechanical Ventilation) 01/2021
1	Radiotherapy 07/2014